Tarsus Pharmaceuticals Inc (TARS)

NASDAQ · Pharmaceuticals

70.51
-0.11 (-0.15%)
Updated Aug 18, 6:06 PM ET
AI Rating
Buy
Overall Score
64
Trend
56
Momentum
88
Risk
44

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Tarsus Pharmaceuticals Inc is trading at $70.51, down 0.15% on the session. The 50 day average sits at $62.23 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 65.6, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $60.08 with resistance near $69.48, so that band frames the current range. Average daily movement is roughly $3.35, or about 4.7% of the share price, which is what any stop placement has to allow for. The overall health score of 64 out of 100 combines a trend score of 56, momentum of 88 and a risk score of 44.

Technical indicators

RSI (14)
65.6
strong
MACD
2.195
bullish crossover
SMA 20
62.18
SMA 50
62.23
SMA 200
--
unknown
ATR (14)
3.35
avg daily range
Support
60.08
Resistance
69.48
Volume vs 20d
0.52x
below average
Volatility
42.2%
annualised
1 month
+19.95%
3 months
+6.17%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.